Jonathan Lambert

Yeah, these are essentially the overhead costs of conducting medical studies to search for new cures for everything from cancer and heart disease to addiction and Alzheimer's. You know, think about electricity to keep the lights on, janitors to clean buildings and take out the trash. Researchers said the cap would essentially cripple medical research.

Yeah, these are essentially the overhead costs of conducting medical studies to search for new cures for everything from cancer and heart disease to addiction and Alzheimer's. You know, think about electricity to keep the lights on, janitors to clean buildings and take out the trash. Researchers said the cap would essentially cripple medical research.

Yeah, these are essentially the overhead costs of conducting medical studies to search for new cures for everything from cancer and heart disease to addiction and Alzheimer's. You know, think about electricity to keep the lights on, janitors to clean buildings and take out the trash. Researchers said the cap would essentially cripple medical research.

Don't forget, with a budget of more than $48 billion, the NIH is the world's largest public funder of biomedical research. Yeah. So this was seen as an almost existential threat to the whole U.S. biomedical research enterprise.

Don't forget, with a budget of more than $48 billion, the NIH is the world's largest public funder of biomedical research. Yeah. So this was seen as an almost existential threat to the whole U.S. biomedical research enterprise.

Don't forget, with a budget of more than $48 billion, the NIH is the world's largest public funder of biomedical research. Yeah. So this was seen as an almost existential threat to the whole U.S. biomedical research enterprise.

They said the 15% was more in line with what other funders pay, like, you know, private foundations. and argued that institutions could cover more of these costs themselves by eliminating bloat in their budgets and by dipping into their endowments, especially big, wealthy schools like Harvard and Yale.

They said the 15% was more in line with what other funders pay, like, you know, private foundations. and argued that institutions could cover more of these costs themselves by eliminating bloat in their budgets and by dipping into their endowments, especially big, wealthy schools like Harvard and Yale.

They said the 15% was more in line with what other funders pay, like, you know, private foundations. and argued that institutions could cover more of these costs themselves by eliminating bloat in their budgets and by dipping into their endowments, especially big, wealthy schools like Harvard and Yale.

Though I should note, a federal judge in Boston has blocked the 15% cap on indirect costs from going into effect, so that came as a huge relief to researchers, as you might imagine.

Though I should note, a federal judge in Boston has blocked the 15% cap on indirect costs from going into effect, so that came as a huge relief to researchers, as you might imagine.

Though I should note, a federal judge in Boston has blocked the 15% cap on indirect costs from going into effect, so that came as a huge relief to researchers, as you might imagine.

Yeah, so we estimate that the NIH lost about 1,200 of the agency's 18,000 employees. And since the layoffs were aimed at probationary employees, they were pretty much random, hitting, you know, relatively junior scientists, but also senior investigators who had recently taken new jobs or been promoted. Plus, some top leaders started being forced out.

Yeah, so we estimate that the NIH lost about 1,200 of the agency's 18,000 employees. And since the layoffs were aimed at probationary employees, they were pretty much random, hitting, you know, relatively junior scientists, but also senior investigators who had recently taken new jobs or been promoted. Plus, some top leaders started being forced out.

Yeah, so we estimate that the NIH lost about 1,200 of the agency's 18,000 employees. And since the layoffs were aimed at probationary employees, they were pretty much random, hitting, you know, relatively junior scientists, but also senior investigators who had recently taken new jobs or been promoted. Plus, some top leaders started being forced out.

And most recently, HHS has started offering $25,000 to employees of that agency, and that's part of HHS, if they leave. And there are also rumblings of some senior scientist contracts not being renewed.

And most recently, HHS has started offering $25,000 to employees of that agency, and that's part of HHS, if they leave. And there are also rumblings of some senior scientist contracts not being renewed.

And most recently, HHS has started offering $25,000 to employees of that agency, and that's part of HHS, if they leave. And there are also rumblings of some senior scientist contracts not being renewed.

So the NIH had been blocked from reviewing new grants, but that's been partially lifted. So that whole process of reviewing grant applications has restarted to some degree. At the same time, though, a lot of existing grants have been terminated to comply with the president's executive orders, barring anything related to DEI and the LGBTQ community.

So the NIH had been blocked from reviewing new grants, but that's been partially lifted. So that whole process of reviewing grant applications has restarted to some degree. At the same time, though, a lot of existing grants have been terminated to comply with the president's executive orders, barring anything related to DEI and the LGBTQ community.